These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16887973)

  • 1. Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes.
    Zhou M; Xu D; Li X; Li H; Shan M; Tang J; Wang M; Wang FS; Zhu X; Tao H; He W; Tien P; Gao GF
    J Immunol; 2006 Aug; 177(4):2138-45. PubMed ID: 16887973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins.
    Tsao YP; Lin JY; Jan JT; Leng CH; Chu CC; Yang YC; Chen SL
    Biochem Biophys Res Commun; 2006 May; 344(1):63-71. PubMed ID: 16630549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV.
    Lv Y; Ruan Z; Wang L; Ni B; Wu Y
    BMC Immunol; 2009 Dec; 10():61. PubMed ID: 19958537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an HLA-A*0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein.
    Wang B; Chen H; Jiang X; Zhang M; Wan T; Li N; Zhou X; Wu Y; Yang F; Yu Y; Wang X; Yang R; Cao X
    Blood; 2004 Jul; 104(1):200-6. PubMed ID: 15016646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein.
    Liu J; Wu P; Gao F; Qi J; Kawana-Tachikawa A; Xie J; Vavricka CJ; Iwamoto A; Li T; Gao GF
    J Virol; 2010 Nov; 84(22):11849-57. PubMed ID: 20844028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes.
    Liu J; Sun Y; Qi J; Chu F; Wu H; Gao F; Li T; Yan J; Gao GF
    J Infect Dis; 2010 Oct; 202(8):1171-80. PubMed ID: 20831383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein.
    Zhao K; Yang B; Xu Y; Wu C
    Vaccine; 2010 Sep; 28(41):6666-74. PubMed ID: 20709007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residue analysis of a CTL epitope of SARS-CoV spike protein by IFN-gamma production and bioinformatics prediction.
    Huang J; Cao Y; Bu X; Wu C
    BMC Immunol; 2012 Sep; 13():50. PubMed ID: 22963340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS.
    Wang YD; Sin WY; Xu GB; Yang HH; Wong TY; Pang XW; He XY; Zhang HG; Ng JN; Cheng CS; Yu J; Meng L; Yang RF; Lai ST; Guo ZH; Xie Y; Chen WF
    J Virol; 2004 Jun; 78(11):5612-8. PubMed ID: 15140958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope.
    Cheung YK; Cheng SC; Sin FW; Chan KT; Xie Y
    Vaccine; 2007 Aug; 25(32):6070-7. PubMed ID: 17629360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of SARS-COV spike protein-derived and HLA-A2-restricted human CTL epitopes by using a new muramyl dipeptidederivative adjuvant.
    Chen YZ; Liu G; Senju S; Wang Q; Irie A; Haruta M; Matsui M; Yasui F; Kohara M; Nishimura Y
    Int J Immunopathol Pharmacol; 2010; 23(1):165-77. PubMed ID: 20378004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1.
    Wilson CC; McKinney D; Anders M; MaWhinney S; Forster J; Crimi C; Southwood S; Sette A; Chesnut R; Newman MJ; Livingston BD
    J Immunol; 2003 Nov; 171(10):5611-23. PubMed ID: 14607970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of immunogenic T-cell epitopes in SARS virus nucleocapsid protein and their role in the prevention and treatment of SARS infection.
    Cheung YK; Cheng SC; Sin FW; Chan KT; Xie Y
    Hong Kong Med J; 2008 Aug; 14 Suppl 4():27-30. PubMed ID: 18708671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice.
    Ohno S; Kohyama S; Taneichi M; Moriya O; Hayashi H; Oda H; Mori M; Kobayashi A; Akatsuka T; Uchida T; Matsui M
    Vaccine; 2009 Jun; 27(29):3912-20. PubMed ID: 19490987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with Th-CTL fusion peptide and cytosine-phosphate-guanine DNA in transgenic HLA-A2 mice induces recognition of HIV-infected T cells and clears vaccinia virus challenge.
    Daftarian P; Ali S; Sharan R; Lacey SF; La Rosa C; Longmate J; Buck C; Siliciano RF; Diamond DJ
    J Immunol; 2003 Oct; 171(8):4028-39. PubMed ID: 14530323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses.
    Huang J; Cao Y; Du J; Bu X; Ma R; Wu C
    Vaccine; 2007 Sep; 25(39-40):6981-91. PubMed ID: 17709158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a.
    Kohyama S; Ohno S; Suda T; Taneichi M; Yokoyama S; Mori M; Kobayashi A; Hayashi H; Uchida T; Matsui M
    Antiviral Res; 2009 Nov; 84(2):168-77. PubMed ID: 19748524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization.
    Loirat D; Lemonnier FA; Michel ML
    J Immunol; 2000 Oct; 165(8):4748-55. PubMed ID: 11035120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of CTL recognizing an HLA-A*0201-restricted epitope shared by MAGE-A1, -A2, -A3, -A4, -A6, -A10, and -A12 tumor antigens: implication in a broad-spectrum tumor immunotherapy.
    Graff-Dubois S; Faure O; Gross DA; Alves P; Scardino A; Chouaib S; Lemonnier FA; Kosmatopoulos K
    J Immunol; 2002 Jul; 169(1):575-80. PubMed ID: 12077290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction and identification of novel IBV S1 protein derived CTL epitopes in chicken.
    Tan L; Liao Y; Fan J; Zhang Y; Mao X; Sun Y; Song C; Qiu X; Meng C; Ding C
    Vaccine; 2016 Jan; 34(3):380-6. PubMed ID: 26620841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.